The Use of LiDCOplus in Fluid Resuscitation Decision-Making
Does the Use of LiDCOplus Alter Decision-making in Fluid Prescription During Resuscitation in the Intensive Care Unit.
1 other identifier
observational
45
1 country
1
Brief Summary
Unwell patients in the intensive care unit (ICU) often need supplementary fluids to be given into the bloodstream through a drip in a vein (venous cannula), however too much fluid can be harmful. It can sometimes be difficult to tell whether or not a patient will benefit from extra fluids so they are given a "fluid challenge", whereby a small volume of fluid is given quickly into the cannula and the change in their status is noted. If the patient's condition improves, this suggests that the patient is "fluid responsive" and needs more fluid. A LiDCOplus haemodynamic monitor is a device used in the ICU to estimate the amount of blood ejected from the heart on each heartbeat using pressure readings obtained from a tube placed in one of the patient's arteries (arterial line). The investigators aim to determine whether or not the use of this device called makes a difference to the judgement of "fluid responsiveness" when the patient is given a fluid challenge when compared to simply using measurements of pulse and blood pressure and assessing the circulation in the patient's limbs. This will allow the investigators to determine whether or not the LiDCOplus alters the decisions made by doctors and nurses about how much fluid to give their patients and hence if it is of any benefit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 22, 2017
CompletedFirst Submitted
Initial submission to the registry
October 25, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2017
CompletedFirst Posted
Study publicly available on registry
November 22, 2017
CompletedNovember 22, 2017
November 1, 2017
7 months
October 25, 2017
November 20, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fluid responsiveness decisions changed by use of LiDCOplus
Proportion of decisions about fluid management changed by knowledge of the change in stroke volume post fluid challenge, as derived by LiDCOplus haemodynamic monitor.
10 minutes
Study Arms (1)
Patients undergoing fluid resuscitation
Adult patients in the intensive care unit (ICU) undergoing fluid resuscitation guided by the LiDCOplus haemodynamic monitor.
Interventions
Patients in study group receive intravenous fluid bolus as part of standard fluid resuscitation. Fluid responsiveness (i.e. improvement in cardiac output) is estimated using both standard clinical parameters and by LiDCOplus haemodynamic monitor (with the clinician initially blinded to the latter) before a final decision about fluid responsiveness is made.
Eligibility Criteria
Adult patients in the Intensive Care Unit (ICU) undergoing fluid resuscitation guided by fluid challenges monitored by a LiDCOplus haemodynamic monitor.
You may qualify if:
- Adult patients
- Admitted to Intensive Care Unit (ICU)
- Undergoing fluid resuscitation guided by fluid challenges
- Monitored by a LiDCOplus haemodynamic monitor attached to an arterial line
You may not qualify if:
- Poor arterial line trace
- Moribund state
- Patient / relative refusal
- Contra-indication to fluid bolus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Glasgow Royal Infirmary
Glasgow, G4 0SF, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
James A Patterson, MBChB
NHS Greater Glasgow and Clyde
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 25, 2017
First Posted
November 22, 2017
Study Start
March 22, 2017
Primary Completion
October 31, 2017
Study Completion
October 31, 2017
Last Updated
November 22, 2017
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will not share